Focused Update on Dual Antiplatelet Therapy (DAPT) – Recommendations for Optimal Duration and Management in Coronary Artery Disease (2016) American Heart AssociationAmerican College of Cardiology (AHAACC) Task Force

Description

This focused update provides crucial revisions and new evidence-based recommendations regarding the duration and composition of dual antiplatelet therapy (DAPT) for patients with acute coronary syndromes (ACS) and those undergoing percutaneous coronary intervention (PCI), addressing balancing ischemic risk and bleeding risk.